KBMED Safety Lancets to Launch in the U.S. Market This June

KB Medical announces that its innovative KBMED Safety Lancet Series will officially enter the U.S. market in June 2026, further expanding the company’s portfolio of advanced diabetes care and clinical safety solutions.

The new product lineup includes:

• Push Button Activated Safety Lancet

• Adjustable Push Button Activated Safety Lancet

Designed for safer and more efficient blood collection, the KBMED Safety Lancet Series features one-button activation, automatic needle retraction, and single-use protection to help reduce needlestick injuries and cross-contamination risks.

Key product advantages include:

• Adjustable penetration depth for different patient needs

• Ultra-fine medical-grade needle design for reduced pain

• Simple one-hand operation for healthcare professionals

• Permanent needle lock after use for enhanced safety

The new lancet series is designed to improve workflow efficiency while enhancing patient comfort and clinical safety in hospitals, clinics, laboratories, and home-care settings.

KB Medical remains committed to developing high-quality medical devices and safer healthcare solutions through continuous innovation.

About KB Medical (Group) Inc.

KB Medical (Group) Inc. is a global medical device manufacturer specializing in high-quality medical disposable products. With advanced manufacturing capabilities and a strong focus on innovation, KB Medical provides OEM/ODM solutions to healthcare providers and distributors worldwide.

For partnership opportunities, distribution inquiries, or OEM customization requests, please visit our website or contact our team directly.